代谢综合征患儿肝前脂肪厚度和腰围变化

doi:10.3969/j.issn.1672-5069.2020.03.019

摘要/Abstract

摘要： 目的研究代谢综合征(MS)儿童肝前脂肪厚度和腰围的变化及其临床意义。方法 2017年2月～2019年2月在我院健康体检儿童445例,发现非酒精性脂肪性肝病(NAFLD)54例,MS 18例,对患儿和从373例健康儿童中配比选择54例,分别行超声检查,检测肝前脂肪厚度、腹内脂肪厚度、腰围和颈动脉内中膜层厚度(IMT),并行血清检测。结果 MS患儿肝前脂肪厚度、腹内脂肪厚度和腰围分别为(1.6±0.2)cm、(4.4±1.5)cm 和(83.4±4.8)cm,显著大于健康儿童【分别为(1.3±0.4)cm、(3.4±1.5)cm和(76.8±5.3)cm,P < 0.05】或NAFLD儿童【分别为(1.4±0.3)cm、(3.5±1.6)cm和(80.3±5.0)cm,P < 0.05】;MS患儿胰岛素抵抗指数、高敏C反应蛋白、收缩压和低密度脂蛋白胆固醇水平分别为(5.9±1.6)、(1.8±0.2)mg/L、(136.5±14.0)mmHg和(2.6±0.8)mmol/L,显著大于健康儿童【分别为(3.5±1.7)、(1.4±0.2) mg/L、(110.8±12.7)mmHg和(1.7±0.5)mmol/L,P < 0.05】或NAFLD儿童【分别为(4.2±1.5)、(1.5±0.3)mg/L、(128.9±13.8)mmHg和(2.4±0.7)mmol/L,P < 0.05】,而MS患儿血清高密度脂蛋白胆固醇水平为(1.3±0.5) mmol/L,显著低于健康儿童【(1.8±0.7)mmol/L,P < 0.05】或NAFLD儿童【1.4±0.5)mmol/L,P < 0.05】;Logistic多因素回归分析结果显示肝前脂肪厚度(95% CI =1.098-4.198,OR=2.147,P=0.026)、腰围(95% CI =1.395-4.523,OR =2.512,P=0.002)和腹内脂肪厚度(95% CI =1.332-5.958,OR =2.817,P=0.007)是MS发生的独立危险因素。结论使用超声检测肝前脂肪厚度简单易行,有助于诊断MS儿童,临床应用价值较高。

关键词: 代谢综合征, 非酒精性脂肪性肝病, 肝前脂肪厚度, 腰围, 诊断 , ,

Abstract: Objective The aim of this study was to investigate the change of anterior liver fat thickness (ALFT) and waist circumference (WC) in children with metabolic syndrome (MS). Methods The clinical data of 445 children undergoing physical examination in our hospital between February 2017 and February 2019 were analyzed retrospectively. Out of them, 54 children had non-alcoholic fatty liver disease (NAFLD) and 18 had MS. Another 54 children out of 373 healthy children were selected by age- and gender-matching for control. The ALFT, intra-abdominal fat thickness (IAFT), WC and the intima-media thickness (IMT) of carotid artery were measured by sonography, and serum parameter were also assayed. Results The ALFT, IAFT, WC in children with MS were(1.6±0.2)cm,(4.4±1.5)cm and (83.4±4.8)cm, significantly higher than【(1.3±0.4)cm,(3.4±1.5)cm and (76.8±5.3)cm, respectively, P<0.05】 in healthy or 【(1.4±0.3)cm,(3.5±1.6)cm and (80.3±5.0)cm, P < 0.05】 in children with NAFLD; the homeostasis model assessment of insulin resistance, serum high-sensitivity C-reactive protein level, systolic blood pressure and serum low density lipoprotein cholesterol level in children with MS were(5.9±1.6), (1.8±0.2)mg/L, (136.5±14.0)mmHg and (2.6±0.8)mmol/L, significantly greater than 【(3.5±1.7), (1.4±0.2) mg/L, (110.8±12.7)mmHg and (1.7±0.5)mmol/L, respectively, P < 0.05】 in healthy children or 【(4.2±1.5),(1.5±0.3)mg/L,(128.9±13.8)mmHg and (2.4±0.7)mmol/L, respectively,P < 0.05】 in children with NAFLD, while serum high density lipoprotein cholesterol level was(1.3±0.5) mmol/L, much lower than 【(1.8±0.7)mmol/L,P < 0.05】 in healthy children or 【1.4±0.5)mmol/L, P < 0.05】 in children with NAFLD; the multivariate Logistic analysis showed that ALFT (95% CI =1.098-4.198, OR=2.147, P=0.026), WC(95% CI =1.395-4.523, OR =2.512, P=0.002) and IAFT (95% CI =1.332-5.958, OR =2.817, P=0.007) were the independent risk factors for occurrence of MS in children. Conclusion The detection of ALFT by sonography is simple and easy to do, which might help to determine the presence of MS in children with NAFLD.

Key words: Metabolic syndrome, Non-alcoholic fatty liver disease, Anterior liver fat thickness, Waist circumference, Diagnosis

王丽君,靳广甫,王齐,吴丹,李素娟. 代谢综合征患儿肝前脂肪厚度和腰围变化[J]. 实用肝脏病杂志, 2020, 23(3): 376-379.

Wang Lijun,jin Guangfu,Wang Qi, et al.. Anterior liver fat thickness and waist circumference changes in children with metabolic syndrome[J]. Journal of Practical Hepatology, 2020, 23(3): 376-379.

参考文献

[1] 儿童代谢综合征中国工作组.中国六城市学龄儿童代谢综合征流行现状研究.中华儿科杂志,2013,51(6):409-413.
[2] Al Rifai M , Silverman M G , Nasir K , et al. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the multi-ethnic study of atherosclerosis (MESA).Atherosclerosis,2015,239(2):629-633.
[3] Dagla I ,Benaki D,Baira E , et al. Alteration in the liver metabolome of rats with metabolic syndrome after treatment with hydroxytyrosol. a mass spectrometry and nuclear magnetic resonance-based metabolomics study.Talanta,2017,178(11):246-257.
[4] Laakso M, Johanna K, Alena S, et al. The metabolic syndrome in men study: a resource for studies of metabolic and cardiovascular diseases.J Lipid Res,2017,58(3):481-493.
[5] 董雪莲,张文均.肝脏受控衰减参数检测早期无创发现代谢综合征人群价值分析.实用肝脏病杂志,2018,21(6):50-53.
[6] Iacobellis G , Barbarini G , Letizia C ,et al. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects.Obesity,2014,22(2):332-336.
[7] 中华医学会儿科学分会内分泌遗传代谢学组, 傅君芬, 梁黎. 中国儿童青少年代谢综合征定义和防治建议. 中华儿科杂志, 2012, 50(6):420-422.
[8] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪肝专家委员会.非酒精性脂肪性肝病防治指南 (2018年版).实用肝脏病杂志,2018,21(2):177-186.
[9] Franchini S, Savino A, Marcovecchio M L, et al. The effect of obesity and type 1 diabetes on renal function in children and adolescents. Pediatr Diabe,2015, 16(6):427-433.
[10] Lassale C , Tzoulaki I , Moons K , et al. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur Heart J,2018,39(5):397-406.
[11] Song S J, Paik Y, SongH, et al. Metabolic syndrome risk factors are associated with white rice intake in Korean adolescent girls and boys. Brit J Nutr,2015,113(3):479-487.
[12] Junyong Z , Rongtao C , Zhiming Q , et al. Evaluation of serum lipid profile, body mass index, and waistline in Chinese patients with type 2 diabetes mellitus. Clin Interv Aging,2016,18(11):445-452.
[13] 何宇纳, 赵文华, 赵丽云, 等. 2010-2012年中国10～17岁儿童青少年代谢综合征流行情况. 中华预防医学杂志, 2017, 51(6):513-518.
[14] Moreno-Indias I , Tinahones F J , Clemente-Postigo M , et al. Molecular effect of fenofibrate on PBMC gene transcription related to lipid metabolism in metabolic syndrome patients. Clin Endocrinol,2017,86(6):784-786.
[15] Chai C ,Rivkin M ,Berkovits L ,et al. Metabolic circuit involving free fatty acids, microRNA 122, and triglyceride synthesis in liver and muscle tissues.Gastroenterology,2017,153(5):1404-1415.
[16] Vignini A, Jacopo S, Nicolò C, et al. Preperitoneal fat thicknesses, lipid profile, and oxidative status in women with uterine fibroids. Reprod Sci, 2017, 24(10):1419.
[17] WagnerD R , Thompson B J , Anderson D A , et al. A-mode and B-mode ultrasound measurement of fat thickness: a cadaver validation study. Eur J Clin Nutr,2019,73(4):518-523.
[18] Altin C , Sade L E , Gezmis E , et al. Assessment of subclinical atherosclerosis by carotid intima-media thickness and epicardial adipose tissue thickness in prediabetes. Angiology, 2016,67(10):961-969.
[19] Fukuda K, Seki Y, Ichihi M, et al. Usefulness of ultrasonographic estimation of preperitoneal and subcutaneous fat thickness in the diagnosis of nonalcoholic fatty liver disease in diabetic patients. J Med Ultrason,2015,42(3):1-7.
[20] Runde J, Azzam RK. Hepatobiliary manifestations in systemic disease. Pediatr Ann, 2018,47(11):e458-e464.